All

Scipher Medicine Presents New Data Further Validating PrismRA Test

PrismRA accurately predicted which patients with rheumatoid arthritis would not achieve EULAR good response criteria at six months of treatment using either adalimumab or etanercept.

All

Roche SARS-CoV-2 Molecular Test Granted FDA EUA

Roche has announced that the U.S. FDA has granted EUA for the cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat System.

All

June 2021 Tech Guide: Immunoassay Analyzers

The Tech Guide from the June 2021 issue of Clinical Lab Products includes immunoassay analyzers from Beckman Coulter, Diazyme, Fujirebio, Grifols, Ortho Clinical Diagnostics, Randox, Siemens Healthineers, and more.

Diagnostic Technologies

How Better Diagnostics Technology Could Thwart Tomorrow’s Pandemics

Pandemic preparedness requires long-term investments in disease surveillance, diagnostics, therapeutics, and vaccine research.

Lab Automation

Xmatrx Infinity Expands Possibilities for Clinical Research

Xmatrx Infinity is a platform technology consisting of a fully automated sample processing system, detection kits, antibodies, and probes for molecular diagnostics and translational and clinical research.

Covid 19

COVID Rapid Test Consistently Confirms Presence of Antibodies

A U.S. clinical trial of a COVID-19 rapid test confirmed negative results were 100% (95% CI, 88.4%-100.0%).

Lab Equipment

Speeding Up Cell Culture Workflows with Integra’s Serological Pipettor

The Integra Pipetboy acu 2 offers increased pipetting speed and sensitive liquid control using varying finger pressure, with a lightweight and ergonomic design to reduce pipetting fatigue.

Lab Essentials

Clinical Reference Materials: Key Buying Factors for Maximum Value

Innovations in liquid stable technologies applied to clinical reference materials provide numerous advantages for clinical laboratories.

Disease States

Labcorp, OmniSeq Launch Insight Next-Gen Sequencing Platform for Precision Oncology

OmniSeq Insight is a pan-cancer, solid tumor test that combines two different treatment paradigms: genomic and immune profiling.

Lab Management

Private-Equity Group Reaches Deal to Buy Medline for Over $30 Billion

A huge buyout deal has been reached to acquire family-owned Medline, a manufacturer and distributor of diagnostic equipment and a wide range of medical equipment and supplies, reports the Wall Street Journal.